(INVZ) Innoviz Technologies - Overview
Stock: LiDAR, Sensors, Software
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 99.5% |
| Relative Tail Risk | -18.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.01 |
| Alpha | -57.36 |
| Character TTM | |
|---|---|
| Beta | 1.863 |
| Beta Downside | 1.623 |
| Drawdowns 3y | |
|---|---|
| Max DD | 89.75% |
| CAGR/Max DD | -0.45 |
Description: INVZ Innoviz Technologies December 30, 2025
Innoviz Technologies Ltd. (NASDAQ: INVZ) designs and manufactures automotive-grade LiDAR sensors and accompanying perception software aimed at enabling mass-scale autonomous driving. Its flagship offering, InnovizOne, is a solid-state LiDAR targeted at automakers, robotaxi fleets, shuttles, trucks and delivery services that require a cost-effective, high-volume solution.
Beyond InnovizOne, the firm sells three next-generation sensor families: InnovizTwo Long-Range for high-performance, long-distance perception; InnovizTwo Short- to Mid-Range for close-to-medium range coverage; and a perception software suite that converts raw point-cloud data into actionable object-detection outputs. In FY 2024 the company reported $45 million in revenue, reflecting a 70 % year-over-year increase driven largely by new OEM contracts in Europe and North America.
Innoviz operates globally-from Europe and the Asia-Pacific to the Middle East, Africa, Israel and North America-leveraging a mix of direct sales and distribution partners. The LiDAR market is projected to grow at a compound annual growth rate of roughly 23 % through 2030, supported by tightening safety regulations and the rollout of Level 3-4 autonomous vehicle pilots. For a deeper quantitative assessment, you may find ValueRay’s detailed model on INVZ useful.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -65.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.40 > 0.02 and ΔFCF/TA 12.82 > 1.0 |
| NWC/Revenue: 144.7% < 20% (prev 207.4%; Δ -62.70% < -1%) |
| CFO/TA -0.37 > 3% & CFO -56.6m > Net Income -65.1m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (203.4m) vs 12m ago 21.25% < -2% |
| Gross Margin: 23.49% > 18% (prev -0.12%; Δ 2361 % > 0.5%) |
| Asset Turnover: 32.79% > 50% (prev 22.97%; Δ 9.83% > 0%) |
| Interest Coverage Ratio: -45.43 > 6 (EBITDA TTM -60.0m / Interest Expense TTM 1.45m) |
Altman Z'' -15.00
| A: 0.46 (Total Current Assets 102.2m - Total Current Liabilities 32.1m) / Total Assets 151.1m |
| B: -5.14 (Retained Earnings -776.6m / Total Assets 151.1m) |
| C: -0.44 (EBIT TTM -65.6m / Avg Total Assets 147.7m) |
| D: -12.65 (Book Value of Equity -776.6m / Total Liabilities 61.4m) |
| Altman-Z'' Score: -29.98 = D |
Beneish M -0.35
| DSRI: 3.83 (Receivables 19.8m/3.54m, Revenue 48.4m/33.2m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.12 (AQ_t 0.02 / AQ_t-1 0.02) |
| SGI: 1.46 (Revenue 48.4m / 33.2m) |
| TATA: -0.06 (NI -65.1m - CFO -56.6m) / TA 151.1m) |
| Beneish M-Score: -0.35 (Cap -4..+1) = D |
What is the price of INVZ shares?
Over the past week, the price has changed by +5.02%, over one month by -14.41%, over three months by -39.16% and over the past year by -36.88%.
Is INVZ a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the INVZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.7 | 162.4% |
| Analysts Target Price | 2.7 | 162.4% |
| ValueRay Target Price | 0.7 | -31.7% |
INVZ Fundamental Data Overview February 02, 2026
P/B = 2.2705
Revenue TTM = 48.4m USD
EBIT TTM = -65.6m USD
EBITDA TTM = -60.0m USD
Long Term Debt = 35.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 5.75m USD (from shortTermDebt, last quarter)
Debt = 35.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 27.1m USD (from netDebt column, last quarter)
Enterprise Value = 161.4m USD (200.8m + Debt 35.0m - CCE 74.4m)
Interest Coverage Ratio = -45.43 (Ebit TTM -65.6m / Interest Expense TTM 1.45m)
EV/FCF = -2.64x (Enterprise Value 161.4m / FCF TTM -61.0m)
FCF Yield = -37.81% (FCF TTM -61.0m / Enterprise Value 161.4m)
FCF Margin = -126.0% (FCF TTM -61.0m / Revenue TTM 48.4m)
Net Margin = -134.5% (Net Income TTM -65.1m / Revenue TTM 48.4m)
Gross Margin = 23.49% ((Revenue TTM 48.4m - Cost of Revenue TTM 37.1m) / Revenue TTM)
Gross Margin QoQ = 15.04% (prev 16.00%)
Tobins Q-Ratio = 1.07 (Enterprise Value 161.4m / Total Assets 151.1m)
Interest Expense / Debt = 4.13% (Interest Expense 1.45m / Debt 35.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -51.9m (EBIT -65.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.18 (Total Current Assets 102.2m / Total Current Liabilities 32.1m)
Debt / Equity = 0.39 (Debt 35.0m / totalStockholderEquity, last quarter 89.7m)
Debt / EBITDA = -0.45 (negative EBITDA) (Net Debt 27.1m / EBITDA -60.0m)
Debt / FCF = -0.44 (negative FCF - burning cash) (Net Debt 27.1m / FCF TTM -61.0m)
Total Stockholder Equity = 92.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -44.10% (Net Income -65.1m / Total Assets 151.1m)
RoE = -70.52% (Net Income TTM -65.1m / Total Stockholder Equity 92.4m)
RoCE = -51.54% (EBIT -65.6m / Capital Employed (Equity 92.4m + L.T.Debt 35.0m))
RoIC = -56.14% (negative operating profit) (NOPAT -51.9m / Invested Capital 92.4m)
WACC = 11.37% (E(200.8m)/V(235.8m) * Re(12.78%) + D(35.0m)/V(235.8m) * Rd(4.13%) * (1-Tc(0.21)))
Discount Rate = 12.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 11.00%
Fair Price DCF = unknown (Cash Flow -61.0m)
EPS Correlation: 92.43 | EPS CAGR: 59.74% | SUE: 4.0 | # QB: 1
Revenue Correlation: 83.53 | Revenue CAGR: 80.89% | SUE: 0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.07 | Chg30d=+0.013 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=-0.28 | Chg30d=-0.035 | Revisions Net=+0 | Growth EPS=+4.6% | Growth Revenue=+45.1%